Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. Bardia A, Hu X, Dent R, Yonemori K, et al. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2407086.

Read + Share

Amedeo Smart

Independent Medical Education

Bardia A, Hu X, Dent R, Yonemori K, et al. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. N Engl J Med 2024 Sep 15. doi: 10.1056/NEJMoa2407086.
PMID: 39282896